scispace - formally typeset
G

Giulia Bulli

Researcher at University of Naples Federico II

Publications -  12
Citations -  2474

Giulia Bulli is an academic researcher from University of Naples Federico II. The author has contributed to research in topics: Sarcopenia & Blood pressure. The author has an hindex of 7, co-authored 12 publications receiving 1363 citations.

Papers
More filters
Journal ArticleDOI

Oxidative stress, aging, and diseases.

TL;DR: Given the important role of oxidative stress in the pathogenesis of many clinical conditions and aging, antioxidant therapy could positively affect the natural history of several diseases, but further investigation is needed to evaluate the real efficacy of these therapeutic interventions.
Journal ArticleDOI

Sarcopenia: assessment of disease burden and strategies to improve outcomes.

TL;DR: Because sarcopenia is associated with important adverse health outcomes, such as frailty, hospitalization, and mortality, several therapeutic strategies have been identified that involve exercise training, nutritional supplementation, hormonal therapies, and novel strategies and are still under investigation.
Journal ArticleDOI

The Italian version of the “frailty index” based on deficits in health: a validation study

TL;DR: IFi is a valid measure of frailty after the comprehensive geriatric assessment in an Italian cohort of non-institutionalized patients and area under curve (AUC) was evaluated for both Fried’s and IFi frailty index.
Journal ArticleDOI

Orthostatic Hypotension in the Elderly: A Marker of Clinical Frailty?

TL;DR: OH is a common condition in frail older adults, and it is strongly associated with mortality, disability, and hospitalization in the highest frailty degree, and may represent a new marker of clinical frailty.
Journal ArticleDOI

Impact of SPRINT results on hypertension guidelines: implications for "frail" elderly patients.

TL;DR: It has been described that light frailty is related to good outcomes in older adults and frailty status should be routinely and correctly quantified in order to identify the frailty degree and to find the best harms–benefits balance of antihypertensive drug treatment in frail older adults.